The Role of the Olfactory System in Obesity and Metabolism in Humans: A Systematic Review and Meta-Analysis

Metabolites. 2023 Dec 25;14(1):16. doi: 10.3390/metabo14010016.

Abstract

Obesity, linked to chronic diseases, poses a global health challenge. While the role of the olfactory system in energy homeostasis is well-documented in rodents, its role in metabolism regulation and obesity in humans remains understudied. This review examines the interplay between olfactory function and metabolic alterations in human obesity and the effects of bariatric surgery on olfactory capabilities in humans. Adhering to PRISMA guidelines, a systematic review and meta-analysis was conducted, focusing exclusively on original human studies. From 51 articles, 14 were selected for the meta-analysis. It was found that variations in olfactory receptor genes influence the susceptibility to odors and predisposition to weight gain and poor eating habits. Bariatric surgery, particularly sleeve gastrectomy, shows significant improvements in olfactory function (SMD 2.37, 95% CI [0.96, 3.77], I = 92%, p = 0.001), especially regarding the olfactory threshold (SMD -1.65, 95% CI [-3.03, -0.27], I = 81%, p = 0.02). There is a bidirectional relationship between olfactory function and metabolism in humans. Bariatric surgery improves olfactory perception in obese patients, but it is still unclear if impacting the olfactory system directly affects eating behavior and the energy balance. However, these findings open novel avenues for future studies addressing the olfactory system as a novel target to alter systemic metabolism in humans.

Keywords: bariatric surgery outcomes; genetic variations in olfactory receptors; metabolic syndrome; metabolism; obesity; odor; olfactory function; smell; weight management.

Publication types

  • Review

Grants and funding

This research was funded by internal funds of K.T. K.T. received research grants from Fondation Machaon (Geneva); the Goldschmidt-Jacobson Foundation (Basel); the Gottfried and Julia Bangerter-Rhyner Foundation; the Novartis Foundation for Medical-Biological Research; Novo Nordisk; the Olga Mayenfisch Foundation; the propatient Research Foundation of University Hospital Basel; the Swiss Diabetes Association; the Swiss National Science Foundation (PCEFP3_194627); the Vontobel Research Foundation; and the University of Basel.